Hypothesis

Midday exposure to green light (520‑560 nm) enhances PER2 transcription in peripheral leukocytes through a melanopsin‑independent, cone‑opsin pathway that modulates ipRGC firing patterns, thereby amplifying circadian amplitude and improving metabolic homeostasis, particularly in individuals carrying the CRY1 variant rs12364283.

Rationale

• ipRGs receive excitatory input from M‑cone (green‑preferring) bipolar cells, which can shift ipRGC spike timing without changing overall melanopsin activation [2].
• Green light preferentially stimulates M‑cones, leading to a distinct calcium signal in ipRGCs that favors CREB‑mediated PER2 upregulation over the melatonin‑suppressive pathway driven by blue light [1].
• PER2 amplitude correlates with glucose tolerance and heart‑rate variability; boosting PER2 may counteract the metabolic dysregulation observed in CRY1‑variant carriers [3]

Predictions

1. Acute PER2 response – Thirty minutes of 1000 lux green light at solar noon will increase PER2 mRNA in blood leukocytes by ≥25 % relative to dim‑light (<10 lux) controls, an effect absent when participants wear M‑cone‑blocking filters.
2. Phase‑independent amplitude – The PER2 increase will occur without a measurable shift in melatonin onset or core body temperature phase, indicating an amplitude‑specific effect.
3. Genotype interaction – CRY1 rs12364283 carriers will show a ≥40 % larger PER2 increase than non‑carriers, reflecting heightened sensitivity to cone‑opsin signaling.
4. Metabolic read‑out – Two‑hours post‑exposure, carriers will exhibit a 10 % reduction in postprandial glucose AUC compared with baseline, an improvement not seen in non‑carriers.

Experimental Design

• Participants: 60 healthy adults (30 CRY1 carriers, 30 non‑carriers), balanced for sex and age (20‑35 y). Stratified randomization to light condition.
• Conditions: (a) Green light (525 nm, 1000 lux, 30 min), (b) Blue light (460 nm, matched photon flux), (c) Dim‑light control (<10 lux). All exposures occur between 12:00‑13:00 h under standardized posture and pupillary monitoring.
• Measures: Peripheral blood drawn pre‑exposure, immediately post‑exposure, and 2 h later for PER2 mRNA (qPCR); saliva melatonin hourly for 6 h to assess phase; continuous glucose monitor for post‑meal AUC; heart‑rate variability recorded throughout.
• Controls: M‑cone‑blocking spectacles (cutoff <500 nm) in a subset to test cone‑dependence; melanopsin‑isolating stimuli (blue‑yellow flicker) to verify pathway specificity.

Falsifiability

If green light fails to raise PER2 above control levels, or if the increase is indistinguishable between cone‑blocked and unblocked conditions, the hypothesis is refuted. Likewise, absence of a genotype‑dependent difference or lack of metabolic improvement despite PER2 elevation would invalidate the proposed mechanistic link.

Potential Impact

Confirming this hypothesis would reveal a nuanced spectral toolbox for circadian medicine: targeted green‑light protocols could reinforce clock‑gene amplitude without phase‑shifting side effects, offering a personalized adjunct to blue‑light restriction for metabolic and mood disorders.